SCHEMBL3355264

SCHEMBL3355264

C=CCCC(=O)OC(=O)[C@@H](CC=C)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
ALDH1A1 P00352 1/20 0.40
FAAH O00519 4/20 0.37
MGLL Q99685 2/20 0.37
TSHR P16473 2/20 0.35
MAPT P10636 2/20 0.33
USP2 O75604 1/20 0.33
CYP3A4 P08684 1/20 0.33
RECQL P46063 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ABCC4 O15439 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PTGS1 P23219 1/20 0.30
MMP1 P03956 1/20 0.30
MMP2 P08253 1/20 0.30
MMP3 P08254 1/20 0.30
MMP7 P09237 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23200431 0.84 ALDH1A1 (0.41) LMNAALDH1A1FAAHMGLLTSHR
SCHEMBL8422179 0.83 TSHR (0.39) LMNAALDH1A1TSHRTDP1MMP1
SCHEMBL3355256 0.83 TSHR (0.39) LMNAALDH1A1TSHRTDP1MMP1
SCHEMBL8418425 0.83 TSHR (0.39) LMNAALDH1A1TSHRTDP1MMP1
SCHEMBL4171918 0.82 FAAH (0.40) LMNAALDH1A1FAAHMGLLTSHR
SCHEMBL16310953 0.77 TSHR (0.34) TSHRTDP1MMP1MMP2MMP3
SCHEMBL16236 0.74 ALDH1A1 (0.45) LMNAALDH1A1FAAHMGLLTSHR
SCHEMBL8420441 0.74 KMT2A (0.45) LMNAALDH1A1TSHRSMN1; SMN2TDP1
SCHEMBL2336327 0.74 KMT2A (0.45) LMNAALDH1A1TSHRSMN1; SMN2TDP1
SCHEMBL29085533 0.73 FAAH (0.39) LMNAALDH1A1FAAHMGLLTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2189442-B1 Process and intermediates for the preparation of aliskiren KRKA TOVARNA ZDRAVIL D D NOVO MESTO (SI) 2014-10-01 EP disclosed
EP-2189442-A1 Process and intermediates for the preparation of aliskiren Krka Tovarna Zdravil, D.D., Novo Mesto (SI) 2010-05-26 EP disclosed